In Brief: MOVA
Executive Summary
MOVA: There is no agreement between MOVA and Par for distribution of MOVA's recently approved ANDA for naproxen ("The Pink Sheet" May 8, T&G-15). It was previously incorrectly reported that Par would distribute the product. MOVA reports that it has several ANDAs pending but is not disclosing a specific number...